Mergers & Acquisitions - Mergers & Acquisitions, Alexion Pharmaceuticals


Popular Filters

News briefs: Grunenthal adds to portfolio; Ajinomoto to buy Althea; Alexion's Soliris OKed in Canada


Family-owned German drugmaker Grunenthal has concluded an exclusive license, distribution and supply…

AjinomotoAlexion PharmaceuticalsAlthea TechnologiesEthypharmfentanylGrunenthalMergers & AcquisitionsNeurologicalPharmaceuticalProductionRare diseasesRegulationSoliris

Alexion tells shareholders to reject TRC's unsolicited mini-tender offer


US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) says it has been notified of an , unsolicited "mini-tender"…

Alexion PharmaceuticalsMergers & AcquisitionsPharmaceutical

Alexion to buy Enobia Pharma for potential $1 billion


US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) has reached agreement to acquire privately held Canadian…

Alexion Pharmaceuticalsasfotase alfaEnobia PharmaMergers & AcquisitionsPharmaceuticalRare diseases

Back to top